PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Development Unit, Shamir Medical Center, Zerifin, Israel. efratishai@outlook.com.\', \'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. efratishai@outlook.com.\', \'Research and Development Unit, Shamir Medical Center, Zerifin, Israel.\', \'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Clinical Chemistry Laboratory, Shamir Medical Center, Zerifin, Israel.\', \'Medical Management, Shamir Medical Center, Zerifin, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-96129-6
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34400714
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34400714>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34400714>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all